Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Podocalyxin Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 11 publications
Supplier: R&D Systems MAB1658SP
This item is not returnable.
View return policy
Description
Podocalyxin Like Monoclonal specifically detects Podocalyxin Like in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF-ready.Specifications
Podocalyxin Like | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
AAB61574 | |
PODXL | |
Mouse myeloma cell line NS0-derived recombinant human Podocalyxin Ser23-Arg427 Accession # AAB61574 | |
25 μg | |
Primary | |
Detects human Podocalyxin in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant mouse Podocalyxin or recombinant human Endoglycan is observed. | |
Human | |
Purified |
Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF | |
222328 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
GCTM, Gp200MGC138240, PCLP, PCLP1, PCLP-1, PCLPGCTM-2 antigen, PCpodocalyxin, POD XL, podocalyxin-like, Podocalyxin-like protein 1, PODXL | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
5420 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction